TRT for body image: what the science says about 'optimization'

What did @hendrxhealth actually say?

The claim here is refreshingly simple. When patients ask if starting TRT will make them look like their doctor, @hendrxhealth says no, adding that even matching his results might take "20 years" or require being "more efficient" than he is. He closes with a reasonable caution: chasing someone else's physique is a poor strategy for success. This is a rare moment of managed expectations in a space that usually runs on before-and-after hype.

He does not promise specific outcomes. He does not cite a dose, a protocol, or a timeline that applies universally. For a TRT content creator on TikTok, that restraint is notable. The core message is that individual variation matters and comparison-based goals tend to backfire.

Does the science back this up?

Yes, substantially. The variability in response to testosterone therapy is one of the more well-documented and underappreciated facts in this space. Individual outcomes depend on baseline testosterone levels, androgen receptor sensitivity, age, body composition, diet, training history, sleep quality, and genetics. Two men on identical protocols can have dramatically different results.

Bhasin et al. (2001, New England Journal of Medicine) showed dose-dependent increases in muscle mass and strength with testosterone, but the variance between individuals was significant even within the same dose groups. Later work by Travison et al. (2011, Journal of Clinical Endocrinology and Metabolism) confirmed that symptomatic response to TRT does not correlate neatly with serum testosterone levels alone, meaning the number on a lab report does not predict how someone will feel or look. The 20-year timeframe @hendrxhealth references is anecdotal, but the underlying point, that physique outcomes accumulate over years and vary by person, is biologically sound.

What did they get wrong (or right)?

He largely got this right. The psychological point about not anchoring your goals to someone else's body is also supported by behavioral health research. A goal framed around copying another person's outcome is harder to sustain and harder to define as success. Locke and Latham's goal-setting theory, which has been applied broadly in health behavior research, consistently shows that specific, self-referenced goals outperform comparison-based ones.

What he does not address, and what a more complete conversation would include, is why individual variation in TRT response exists at all. Androgen receptor gene polymorphisms, particularly CAG repeat length on the AR gene, are associated with receptor sensitivity differences (Zitzmann and Nieschlag, 2003, Trends in Endocrinology and Metabolism). A patient with lower receptor sensitivity may show weaker anabolic response to the same testosterone exposure. This is not a criticism of the video, which is short-form content, but anyone watching should know the biology runs deeper than the message suggests.

What should you actually know?

TRT is a medical treatment for hypogonadism, not a physique optimization tool for everyone who wants to look a certain way. When it works well, it can restore energy, libido, mood stability, and lean body mass in men with clinically low testosterone. When it is used outside that context, the risk-benefit math changes considerably.

The comparison trap @hendrxhealth warns against is real and worth taking seriously. Social media has made it easy to see highly optimized bodies attributed entirely to hormone therapy, often without disclosing years of training, diet discipline, or adjunct compounds that are not TRT. Patients who start TRT expecting a specific look are frequently disappointed, and that disappointment sometimes pushes them toward escalating interventions that carry real risk.

• Get baseline labs before any protocol discussion. Symptoms alone are not sufficient to diagnose hypogonadism.
• Understand that lean mass gains from TRT in eugonadal men are modest. Bhasin et al. (2001) found meaningful gains in hypogonadal men, but effects in men with normal baseline levels are far smaller.
• Timeline matters. Most clinical guidelines suggest evaluating TRT response over 3 to 6 months before adjusting.